Skip to main content
. 2016 Nov-Dec;5(6):373–376. doi: 10.4103/2303-9027.195870

Figure 1.

Figure 1

Typical benign G1 neuroendocrine tumor with early homogeneous strong hyperenhancement. (a) Image immediately after injection. (b) Image 20 s after injection